Peer Review Congress Unveils Study on Generative AI Usage in Cancer Research

A study presented at the 10th Peer Review Congress in September 2025 evaluated the ability to reliably detect generative AI (genAI) use by authors and reviewers in cancer research. The research quantified genAI usage over time and assessed the impact of a policy change on reviewers' use of such tools. The findings offer insights into the evolving role of AI in academic publishing and peer review.